ALLO stock · AMD stock

ALLO vs AMD · rev $22.0K vs P/E 157, rev $11.54B

Allogene Therapeutics Inc (ALLO) versus Advanced Micro Devices Inc (AMD) — a side-by-side from cached financials, not a winner call.

Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.

Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.

Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.

Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.

ALLO currently screens at market cap $258.1M. AMD currently screens at market cap $760.48B and trailing P/E 156.5.

Not investment advice. Open the ALLO and AMD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons